BENZTROPINE MESYLATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Benztropine Mesylate, and when can generic versions of Benztropine Mesylate launch?
Benztropine Mesylate is a drug marketed by Fresenius Kabi Usa, Hikma, Hikma Farmaceutica, Luitpold, Navinta Llc, Aiping Pharm Inc, Chartwell Rx, Endo Operations, Epic Pharma Llc, Invagen Pharms, Lannett Co Inc, Leading, Nuvo Pharm, Oxford Pharms, Pliva, Quantum Pharmics, and Usl Pharma. and is included in twenty-seven NDAs.
The generic ingredient in BENZTROPINE MESYLATE is benztropine mesylate. There are seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the benztropine mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Benztropine Mesylate
A generic version of BENZTROPINE MESYLATE was approved as benztropine mesylate by PLIVA on August 10th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BENZTROPINE MESYLATE?
- What are the global sales for BENZTROPINE MESYLATE?
- What is Average Wholesale Price for BENZTROPINE MESYLATE?
Summary for BENZTROPINE MESYLATE
| US Patents: | 0 |
| Applicants: | 17 |
| NDAs: | 27 |
| Finished Product Suppliers / Packagers: | 20 |
| Raw Ingredient (Bulk) Api Vendors: | 124 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,294 |
| Drug Prices: | Drug price information for BENZTROPINE MESYLATE |
| Drug Sales Revenues: | Drug sales revenues for BENZTROPINE MESYLATE |
| What excipients (inactive ingredients) are in BENZTROPINE MESYLATE? | BENZTROPINE MESYLATE excipients list |
| DailyMed Link: | BENZTROPINE MESYLATE at DailyMed |
See drug prices for BENZTROPINE MESYLATE
Recent Clinical Trials for BENZTROPINE MESYLATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Boehringer Ingelheim | Phase 2 |
Pharmacology for BENZTROPINE MESYLATE
| Drug Class | Anticholinergic Antihistamine |
| Mechanism of Action | Cholinergic Antagonists Histamine Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for BENZTROPINE MESYLATE
US Patents and Regulatory Information for BENZTROPINE MESYLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Usl Pharma | BENZTROPINE MESYLATE | benztropine mesylate | TABLET;ORAL | 089213-001 | Jun 14, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Oxford Pharms | BENZTROPINE MESYLATE | benztropine mesylate | TABLET;ORAL | 040706-001 | Feb 14, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Nuvo Pharm | BENZTROPINE MESYLATE | benztropine mesylate | TABLET;ORAL | 204713-002 | Apr 14, 2015 | AA | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pliva | BENZTROPINE MESYLATE | benztropine mesylate | TABLET;ORAL | 089058-001 | Aug 10, 1988 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Nuvo Pharm | BENZTROPINE MESYLATE | benztropine mesylate | TABLET;ORAL | 204713-003 | Apr 14, 2015 | AA | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | BENZTROPINE MESYLATE | benztropine mesylate | INJECTABLE;INJECTION | 090233-001 | Jul 28, 2009 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Invagen Pharms | BENZTROPINE MESYLATE | benztropine mesylate | TABLET;ORAL | 090294-001 | Mar 29, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
